razoxane has been researched along with vindesine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eiter, H; Rhomberg, W; Saely, CH; Schmid, F | 1 |
| Eiter, H; Ginestet, A; Hackl, A; Lukas, P; Pakisch, B; Pokrajac, B; Pötter, R; Rhomberg, W; Wink, A | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
2 trial(s) available for razoxane and vindesine
| Article | Year |
|---|---|
Combined vindesine and razoxane shows antimetastatic activity in advanced soft tissue sarcomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Humans; Neoplasm Metastasis; Pilot Projects; Radiotherapy; Razoxane; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Vindesine | 2008 |
Treatment of vascular soft tissue sarcomas with razoxane, vindesine, and radiation.
Topics: Aged; Drug Administration Schedule; Female; Hemangiopericytoma; Hemangiosarcoma; Humans; Male; Middle Aged; Radiation-Sensitizing Agents; Radiotherapy Dosage; Razoxane; Vindesine | 2009 |
2 other study(ies) available for razoxane and vindesine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |